Everolimus in combination with exemestane in the treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer who are refractory to letrozole or anastrozole: Preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results